Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Dose Frequency Effects
NCT03610919Phase 1Unknown
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Mar 2018
- Primary completion
- Sep 2018
- Countries
- 1
01
Overview
Phase 1, randomised trial of oxytocin nasal spray in Autism Spectrum Disorder (ASD) (3 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoints: Between group differences in the changes between acute and chronic administration effects of oxytocin on amygdala reactivity towards fearful faces at Day 5 and Between group differences in the changes between acute and chronic administration effects of oxytocin on amygdala resting state connectivity at Day 5. Status: unknown.
02
Drugs
oxytocin nasal spray
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT03610919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03610919.